Literature DB >> 3320742

Purification of the bifunctional thymidylate synthase-dihydrofolate reductase complex from the human malaria parasite Plasmodium falciparum.

G X Chen1, J W Zolg.   

Abstract

The bifunctional thymidylate synthase-dihydrofolate reductase complex from the human malaria parasite Plasmodium falciparum has been purified to homogeneity using a sequence of separation steps including phenyl-Superose, gel filtration, dye affinity matrix, hydroxyapatite, and anion exchange chromatography. The specific activity of dihydrofolate reductase increased approximately 24,000-fold from 3.3 units mg-1 protein to 79,000 units mg-1 protein after five successive chromatographic steps with a yield of 31%. Both enzyme activities coeluted as a symmetric peak in highly purified preparations, indicating the existence of a bifunctional enzyme complex in P. falciparum. The apparent molecular weight of the native complex was approximately 120,000 as determined by gel filtration. When individual fractions of the anion exchange column were subject to polyacrylamide electrophoresis under denaturing conditions, the increase in intensity of a single band correlated with the amount of both the thymidylate synthase and dihydrofolate reductase activity. Further purification led to an electrophoretically pure protein (yield 2.6%) with an apparent molecular weight of 67,000, suggesting that the bifunctional enzyme complex from P. falciparum is composed of two subunits of identical size and charge.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3320742

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  8 in total

1.  Essential protein-protein interactions between Plasmodium falciparum thymidylate synthase and dihydrofolate reductase domains.

Authors:  S Shallom; K Zhang; L Jiang; P K Rathod
Journal:  J Biol Chem       Date:  1999-12-31       Impact factor: 5.157

2.  Selective activity of 5-fluoroorotic acid against Plasmodium falciparum in vitro.

Authors:  P K Rathod; A Khatri; T Hubbert; W K Milhous
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

3.  Potent and selective activity of a combination of thymidine and 1843U89, a folate-based thymidylate synthase inhibitor, against Plasmodium falciparum.

Authors:  L Jiang; P C Lee; J White; P K Rathod
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

4.  Kinetics of Plasmodium falciparum thymidylate synthase: interactions with high-affinity metabolites of 5-fluoroorotate and D1694.

Authors:  M Hekmat-Nejad; P K Rathod
Journal:  Antimicrob Agents Chemother       Date:  1996-07       Impact factor: 5.191

5.  Susceptibility of Plasmodium falciparum to a combination of thymidine and ICI D1694, a quinazoline antifolate directed at thymidylate synthase.

Authors:  P K Rathod; S Reshmi
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

6.  Selection and characterization of 5-fluoroorotate-resistant Plasmodium falciparum.

Authors:  P K Rathod; M Khosla; S Gassis; R D Young; C Lutz
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

7.  Pyrimethamine-resistant dihydrofolate reductase enzymes of Plasmodium falciparum are not enzymatically compromised in vitro.

Authors:  Conner I Sandefur; Jason M Wooden; Isaac K Quaye; Worachart Sirawaraporn; Carol Hopkins Sibley
Journal:  Mol Biochem Parasitol       Date:  2007-03-20       Impact factor: 1.759

8.  Molecular targets of 5-fluoroorotate in the human malaria parasite, Plasmodium falciparum.

Authors:  P K Rathod; N P Leffers; R D Young
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.